{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:27:11Z","timestamp":1790958431675,"version":"4.1.0"},"reference-count":62,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Herein is reported the synthesis of two Au(III) complexes bearing the (R,R)-(\u2013)-2,3-Bis(tert-butylmethylphosphino)quinoxaline (R,R-QuinoxP*) or (S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxaline (S,S-QuinoxP*) ligands. By reacting two stoichiometric equivalents of HAuCl4.3H2O to one equivalent of the corresponding QuinoxP* ligand, (R,R)-(\u2013)-2,3-Bis(tert-butylmethylphosphino)quinoxalinedichlorogold(III) tetrachloroaurates(III) (1) and (S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxalinedichlorogold(III) tetrachloroaurates(III) (2) were formed, respectively, in moderate yields. The structure of (S,S)-(+)-2,3-Bis(tert-butylmethylphosphino)quinoxalinedichlorogold(III) tetrachloroaurates(III) (2) was further confirmed by X-ray crystallography. The antiproliferative activities of the two compounds were evaluated in a panel of cell lines and exhibited promising results comparable to auranofin and cisplatin with IC50 values between 1.08 and 4.83 \u00b5M. It is noteworthy that in comparison to other platinum and ruthenium enantiomeric complexes, the two enantiomers (1 and 2) do not exhibit different cytotoxic effects. The compounds exhibited stability in biologically relevant media over 48 h as well as inert reactivity to excess glutathione at 37 \u00b0C. These results demonstrate that the Au(III) atom, stabilized by the QuinoxP* ligand, can provide exciting compounds for novel anticancer drugs. These complexes provide a new scaffold to further develop a robust and diverse library of chiral phosphorus Au(III) complexes.<\/jats:p>","DOI":"10.3390\/molecules25235735","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T22:15:36Z","timestamp":1607638536000},"page":"5735","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Synthesis, Characterization, and Antiproliferative Activity of Novel Chiral [QuinoxP*AuCl2]+ Complexes"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3076-264X","authenticated-orcid":false,"given":"Adedamola S.","family":"Arojojoye","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Tyler","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-9543","authenticated-orcid":false,"given":"Samuel","family":"Ofori","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5777-3918","authenticated-orcid":false,"given":"Sean R.","family":"Parkin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G.","family":"Awuah","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, USA"},{"name":"Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY 40536, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: A new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1021\/acs.chemrev.8b00685","article-title":"Introduction: Metals in Medicine","volume":"119","author":"Franz","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_3","unstructured":"McCleverty, J.A., and Meyer, T.J. (2003). Comprehensive Coordination Chemistry II, Elsevier."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/clinids\/12.Supplement_1.S3","article-title":"Bismuth subsalicylate: History, chemistry, and safety","volume":"12","author":"Bierer","year":"1990","journal-title":"Rev. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1021\/jm00152a009","article-title":"Correlation of the in vitro cytotoxic and in vivo antitumor activities of gold (I) coordination complexes","volume":"29","author":"Mirabell","year":"1986","journal-title":"J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.biochi.2019.03.015","article-title":"Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug","volume":"162","author":"Zhang","year":"2019","journal-title":"Biochimie"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40268-015-0083-y","article-title":"Auranofin: Repurposing an old drug for a golden new age","volume":"15","author":"Roder","year":"2015","journal-title":"Drugs R.D."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41571-020-0378-y","article-title":"The changing landscape of cancer in the USA\u2014Opportunities for advancing prevention and treatment","volume":"17","author":"Islami","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","unstructured":"Fischer, J., Ganellin, C.R., Ganesan, A., and Proudfoot, J. (2010). ABDD, Wiley-VCH."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/sj.leu.2403021","article-title":"Opportunities for Trisenox\u00ae(arsenic trioxide) in the treatment of myelodysplastic syndromes","volume":"17","author":"List","year":"2003","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9326","DOI":"10.1021\/acs.inorgchem.9b01031","article-title":"Cyclometalated Gold (III) complexes bearing DACH ligands","volume":"58","author":"Gukathasan","year":"2019","journal-title":"Inorg. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10465","DOI":"10.1039\/D0SC03628E","article-title":"Cancer cell-selective modulation of mitochondrial respiration and metabolism by potent organogold (iii) dithiocarbamates","volume":"11","author":"Mertens","year":"2020","journal-title":"Chem. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1021\/acs.jmedchem.9b01436","article-title":"Distorted Gold (I)\u2013Phosphine Complexes as Antifungal Agents","volume":"63","author":"Dennis","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1038\/s41598-019-48584-5","article-title":"Gold(I\/III)-Phosphine Complexes as Potent Antiproliferative Agents","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_16","unstructured":"Lopez, M.J., and Mohiuddin, S.S. (2020). Biochemistry, Essential Amino Acids. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1039\/C8DT00089A","article-title":"Chirality in metal-based anticancer agents","volume":"47","author":"Wang","year":"2018","journal-title":"Dalton Trans."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1021\/ja01470a052","article-title":"Stereospecificity in a new type of synthetic antituberculous agent1,2","volume":"83","author":"Wilkinson","year":"1961","journal-title":"J. Am. Chem. Soc."},{"key":"ref_19","first-page":"332","article-title":"In Ethambutol and related compounds. Synthesis and stereochemical relations","volume":"145","author":"Kritsyn","year":"1962","journal-title":"Daklady Akademii Nawk"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1289\/ehp.02110s5779","article-title":"Chiral discrimination in platinum anticancer drugs","volume":"110","author":"Benedetti","year":"2002","journal-title":"Environ. Health Perspect."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1595\/003214096X403102109","article-title":"Chiral complexes of platinum metals","volume":"40","year":"1996","journal-title":"Platin. Metals Rev."},{"key":"ref_22","first-page":"281","article-title":"Synthesis, Mutagenicity, Binding to pBR 322 DNA and Antitumour Activity of Platinum (II) Complexes","volume":"11","author":"Coluccia","year":"1991","journal-title":"Anticancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1071\/BI9560371","article-title":"Biological Activity of Complex Ions Mechanism of Inhibition of Acetylcholinesterase","volume":"9","author":"Koch","year":"1956","journal-title":"Aust. J. Biol. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ccr.2014.07.016","article-title":"Effect of chirality in platinum drugs","volume":"284","author":"Arnesano","year":"2015","journal-title":"Coord. Chem. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/cbic.200600117","article-title":"Organometallic compounds with biological activity: A very selective and highly potent cellular inhibitor for glycogen synthase kinase 3","volume":"7","author":"Williams","year":"2006","journal-title":"ChemBioChem"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Romero, M.J., and Sadler, P.J. (2014). Chirality in Organometallic Anticancer Complexes. Bioorganometallic Chemistry, Wiley-VCH Verlag GmbH & Co. KGaA.","DOI":"10.1002\/9783527673438.ch03"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1002\/chem.201302183","article-title":"Mirror-Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity","volume":"19","author":"Fu","year":"2013","journal-title":"Chem. Eur. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5623","DOI":"10.1039\/c3dt00015j","article-title":"Thioether-based anchimeric assistance for asymmetric coordination chemistry with ruthenium (II) and osmium (II)","volume":"42","author":"Chen","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/ejic.201500087","article-title":"Probing chiral recognition of enzyme active sites with octahedral iridium (III) propeller complexes","volume":"2015","author":"Ritterbusch","year":"2015","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1021\/acs.jmedchem.6b00112","article-title":"Identification of an iridium (III)-based inhibitor of tumor necrosis factor-\u03b1","volume":"59","author":"Kang","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"8111","DOI":"10.1021\/acs.inorgchem.5b01349","article-title":"Correlation between the Stereochemistry and Bioactivity in Octahedral Rhodium Prolinato Complexes","volume":"54","author":"Rajaratnam","year":"2015","journal-title":"Inorg. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1387-7003(00)00094-0","article-title":"A one-step synthesis of protected functionalised titanocene dichlorides","volume":"3","author":"McGowan","year":"2000","journal-title":"Inorg. Chem. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ica.2010.05.020","article-title":"A new series of titanocene dichloride derivatives bearing chiral alkylammonium groups; assessment of their cytotoxic properties","volume":"364","author":"Potter","year":"2010","journal-title":"Inorg. Chim. Acta"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00432-010-0924-6","article-title":"Iron containing anti-tumoral agents: Unexpected apoptosis-inducing activity of a ferrocene amino acid derivative","volume":"137","author":"Kater","year":"2011","journal-title":"J. Cancer Res. Clin."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ica.2012.06.007","article-title":"Metallocenes as target specific drugs for cancer treatment","volume":"393","year":"2012","journal-title":"Inorg. Chim. Acta"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1021\/om4003126","article-title":"Ferrocene\u2013biotin conjugates targeting cancer cells: Synthesis, interaction with avidin, cytotoxic properties and the crystal structure of the complex of avidin with a biotin\u2013linker\u2013ferrocene conjugate","volume":"32","author":"Plazuk","year":"2013","journal-title":"Organometallics"},{"key":"ref_37","first-page":"108","article-title":"New ferrocene containing peptide conjugates: Synthesis and effect on human leukemia (HL-60) cells","volume":"88","author":"Szabo","year":"2007","journal-title":"Pept. Sci. Orig. Res. Biomol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"7440","DOI":"10.1039\/c3dt32844a","article-title":"Human cancerous and healthy cell cytotoxicity studies of a chiral \u03bc-dicarbene\u2013digold (I) metallamacrocycle","volume":"42","author":"Mullick","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.ejmech.2015.05.027","article-title":"Highly selective anti-cancer properties of ester functionalized enantiopure dinuclear gold (I)-diphosphine","volume":"98","author":"Li","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/S0957-4166(99)00106-8","article-title":"Synthesis and anti-cancer activities of a pair of enantiomeric gold (I) complexes containing sulfanyl-substituted P-stereogenic phosphines","volume":"10","author":"Song","year":"1999","journal-title":"Tetrahedron Asymmetry"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1107\/S002188980600731X","article-title":"Mercury: Visualization and analysis of crystal structures","volume":"39","author":"Macrae","year":"2006","journal-title":"J. Appl. Crystallog."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1039\/C3MT00265A","article-title":"Interactions of gold-based drugs with proteins: Crystal structure of the adduct formed between ribonuclease A and a cytotoxic gold (III) compound","volume":"6","author":"Messori","year":"2014","journal-title":"Metallomics"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/ml500231b","article-title":"Protein recognition of gold-based drugs: 3D structure of the complex formed when lysozyme reacts with Aubipyc","volume":"5","author":"Messori","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/ic501784n","article-title":"[Au (dien)(N-heterocycle)] 3+: Reactivity with biomolecules and zinc finger peptides","volume":"54","author":"Spell","year":"2015","journal-title":"Inorg. Chem."},{"key":"ref_45","first-page":"XC01","article-title":"Cisplatin concentrations in long and short duration infusion: Implications for the optimal time of radiation delivery","volume":"10","author":"Rajkumar","year":"2016","journal-title":"J. Clin. Diag. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1039\/c3md00076a","article-title":"TrxR inhibition and antiproliferative activities of structurally diverse gold N-heterocyclic carbene complexes","volume":"4","author":"Rubbiani","year":"2013","journal-title":"MedChemComm"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jinorgbio.2011.11.007","article-title":"Gold (III) complexes with 2-substituted pyridines as experimental anticancer agents: Solution behavior, reactions with model proteins, antiproliferative properties","volume":"108","author":"Maiore","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1039\/c0dt01057j","article-title":"Bioinorganic and medicinal chemistry: Aspects of gold (I)-protein complexes","volume":"40","author":"Bhabak","year":"2011","journal-title":"Dalton Trans."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"13428","DOI":"10.1002\/chem.201302550","article-title":"Insights into the reactivity of gold\u2013dithiocarbamato anticancer agents toward model biomolecules by using multinuclear NMR spectroscopy","volume":"19","author":"Boscutti","year":"2013","journal-title":"Chem. Eur. J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1039\/C8MT00225H","article-title":"Cyclometallated Au (III) dithiocarbamate complexes: Synthesis, anticancer evaluation and mechanistic studies","volume":"10","author":"Williams","year":"2018","journal-title":"Metallomics"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"Yang","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_52","first-page":"5","article-title":"Electrochemical series","volume":"93","year":"2012","journal-title":"Handb. Chem. Phys."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1107\/S0021889898005305","article-title":"Macromolecular Cryocrystallography: Cooling, Mounting, Storage and Transportation of Crystals","volume":"31","author":"Parkin","year":"1998","journal-title":"J. Appl. Crystallog."},{"key":"ref_54","first-page":"1","article-title":"X-ray crystallography\u2014A fast, first-resort analytical tool","volume":"41","author":"Hope","year":"1994","journal-title":"Prog. Inorg. Chem."},{"key":"ref_55","unstructured":"Bruker (2006). \u201cAPEX2\u201d Bruker-AXS, Bruker."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S1600576714022985","article-title":"Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination","volume":"48","author":"Krause","year":"2015","journal-title":"J. Appl. Crystallogr."},{"key":"ref_57","unstructured":"Sheldrick, G.M. (1997). SADABS, Program for Bruker Area Detector Absorption Correction, University of Gottingen."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C Struct. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT\u2014Integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A Found Adv."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"64","author":"Sheldrick","year":"2008","journal-title":"Acta Crystallogr. Sec. A"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1107\/S090744490804362X","article-title":"Structure validation in chemical crystallography","volume":"65","author":"Spek","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1107\/S0108767300004153","article-title":"Expansion of scalar validation criteria to three dimensions: The R tensor. Erratum","volume":"56","author":"Parkin","year":"2000","journal-title":"Acta Crystallogr. A"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5735\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:41:45Z","timestamp":1760179305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/25\/23\/5735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,4]]},"references-count":62,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["molecules25235735"],"URL":"https:\/\/doi.org\/10.3390\/molecules25235735","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,4]]}}}